NCT03060031View on ClinicalTrials.gov

Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

March 5, 2019

Study Completion Date

April 1, 2019

Conditions
Pain
Interventions
DRUG

Oxytocin

Oxytocin intranasal administration, 40 IU, 5 puffs per nostril at 4 IU per puff delivered approximately 45 minutes prior to pain tasks.

DRUG

Placebo

Placebo intranasal administration, 5 puffs per nostril delivered approximately 45 minutes prior to pain tasks

Trial Locations (1)

80309

Clinical Translational Research Center, Boulder

All Listed Sponsors
lead

University of Colorado, Boulder

OTHER

NCT03060031 - Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain | Biotech Hunter | Biotech Hunter